Study to Evaluate the Effect of Lemborexant Versus Placebo on Driving Performance in Healthy Adult and Elderly Subjects
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo- and active-controlled, 4-period crossover study
of lemborexant in healthy adult and elderly subjects to evaluate driving performance